We have investigated the magnetism and the superconductivity of the electron-doped Pr 1Ϫx LaCe x CuO 4 by means of zero-field muon spin rotation/relaxation and magnetic susceptibility measurements. At low temperatures, a well-defined muon spin rotation free from the effect of rare-earth moments was observed for samples with xр0.08 corresponding to the antiferromagnetic ͑AF͒ order of Cu spins. Bulk superconductivity was identified in a wide Ce concentration range of 0.09рxр0.20 with a maximum transition temperature of 26 K. Abrupt appearance of the superconducting ͑SC͒ phase at xϳ0.09 is concomitant with a destroy of the AF ordered phase, indicating the competitive relation between two phases. Possible relation between the wide SC phase and the lattice spacing is discussed.
We have measured magnetic susceptibility and 51V NMR of CaV2O4, a model substance for a frustrated S = 1 spin chain with competing first- and second-neighbor anti-ferromagnetic interactions. Both the low-temperature magnetic susceptibility and the NMR Knight shift did not go down to zero as the temperature was lowered, suggesting that a spin gap is not present in CaV2O4. The absence of a spin gap gives us a clear contrast to the case of the nonfrustrated spin chains, which should have the Haldane gap. Recently published theoretical results for S = 1 XY or XXZ spin chain indicate that the gapless chiral phase could appear in a relatively broad region. Experimental results are discussed in terms of these theoretical predictions. A spin-freezing anomaly was observed at 20 K, reflecting the spin-frustrating nature of the system. PACS Nos.: 75.30, 75.50
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.